Editas Medicine (EDIT) Other financing activities (2018 - 2022)

Editas Medicine (EDIT) has 5 years of Other financing activities data on file, last reported at $367000.0 in Q2 2022.

• Other financing activities for Q2 2022 came in at $367000.0, down 30.23% year-over-year; the trailing twelve-month figure through Jun 2022 was $1.5 million (changed 0.33% YoY), and the FY2022 annual result was $979000.0, down 15.02% from the prior year.
• Other financing activities eased to $367000.0 in Q2 2022 per EDIT's latest filing, from $526000.0 in the prior quarter.
• Over five years, Other financing activities peaked at $526000.0 in Q2 2021 and troughed at $100000.0 in Q1 2018.
• A 5-year average of $331333.3 and a median of $356000.0 in 2018 frame the typical range for Other financing activities.
• The sharpest annual moves came in 2021 and 2022: Other financing activities jumped 50.29% in 2021, then plunged 30.23% in 2022.
• A 5-year view of Other financing activities shows it stood at $362000.0 in 2018, then retreated by 21.82% to $283000.0 in 2019, then advanced by 23.67% to $350000.0 in 2020, then jumped by 50.29% to $526000.0 in 2021, then sank by 30.23% to $367000.0 in 2022.
• Business Quant data shows EDIT's Other financing activities at $367000.0 in Q2 2022, $526000.0 in Q2 2021, and $350000.0 in Q2 2020.